Aclaris Therapeutics
ACRS
ACRS
127 hedge funds and large institutions have $957M invested in Aclaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 6 closing their positions.
Holders
127
Holders Change
+12
Holders Change %
+10.43%
% of All Funds
2.2%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
19
Increased
48
Reduced
26
Closed
6
Calls
$362K
Puts
$357K
Net Calls
+$5K
Net Calls Change
-$250K
Top Buyers
1 |
1
Walleye Capital
New York
|
$4.25M |
2 |
2
Charles Schwab
San Francisco,
California
|
$6.34M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$17.6M |
4 |
4
BlackRock
New York
|
$75.7M |
5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$29.2M |